Stock Price Quote

AJANTA PHARMA LTD.

NSE : AJANTPHARMBSE : 532331ISIN CODE : INE031B01049Industry : Pharmaceuticals & DrugsHouse : Vimal Agrawal
BSE1562.35-1.75 (-0.11 %)
PREV CLOSE ( ) 1564.10
OPEN PRICE ( ) 1559.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5342
TODAY'S LOW / HIGH ( )1532.85 1585.55
52 WK LOW / HIGH ( )906.5 1759.35
NSE1563.05-2.2 (-0.14 %)
PREV CLOSE( ) 1565.25
OPEN PRICE ( ) 1545.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1563.05 (74)
VOLUME 111064
TODAY'S LOW / HIGH( ) 1530.05 1584.45
52 WK LOW / HIGH ( )903.4 1759.95
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 31-12 1979
Management Info
Mannalal B Agrawal - Chairman Yogesh M Agrawal - Managing Director
Registered Office

Address Ajanta House,Charkop ,Kandivali (W),
Mumbai,
Maharashtra-400067

Phone 91-22-66061000

Email info@ajantapharma.com

Website www.ajantapharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX

NEWS

11Jun Ajanta Pharma informs about disclosure
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
21Jan Ajanta Pharma informs about newspaper
Pursuant to Regulation 47 of the Listing Regulations, Ajanta Pharma has..
06Nov Ajanta Pharma reports 7% fall in Q2 co
Ajanta Pharma has reported results for second quarter ended September 30..
06Nov Ajanta Pharma advances despite reporti
Ajanta Pharma is currently trading at Rs. 1013.85, up by 11.45 points or..
11Oct Ajanta Pharma informs about company up
As per the requirement of Regulation 7(3) of the SEBI (Listing Obligatio..

Financials

in Millions
QTR Jun 20 ANNUAL 20
Net Profit1156.94411.3
Gross Profit 1584.7 6126.7
Operating Profit 1865.37169.8
Net Sales 5608.521964.2

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Alkem Laboratories (BSE)
peergroup  2831.10 (3.22%)
M.Cap ( in Cr)33850.05
Advanced Enzyme (BSE)
peergroup  272.80 (19.99%)
M.Cap ( in Cr)3046.59
Hester Biosciences (BSE)
peergroup  1747.10 (1.13%)
M.Cap ( in Cr)1486.23
Alembic Pharma (BSE)
peergroup  934.35 (2.04%)
M.Cap ( in Cr)18365.88
Panacea Biotec (BSE)
peergroup  196.80 (4.99%)
M.Cap ( in Cr)1205.41

Shareholding Pattern

MUTUAL FUNDS/UTI 9.51%
NON-INSTITUTION 9.49%
PROMOTERS 70.51%
FI/BANKS/INSURANCE 0.84%
GOVERNMENT 0.74%
FII 0%

About Ajanta Pharma Ltd.

Ajanta Pharma Ltd. was incorporated in the year 1979. Its today's share price is 1562.35. Its current market capitalisation stands at Rs 13633.26 Cr. In the latest quarter, company has reported Gross Sales of Rs. 25878.7 Cr and Total Income of Rs.26800.6 Cr. The company's management includes Anjana Grewal, Prabhakar Dalal, KH Viswanathan, Chandrakant M Khetan, Rajesh M Agrawal, Yogesh M Agrawal, Madhusudan B Agrawal, Mannalal B Agrawal.

It is listed on the BSE with a BSE Code of 532331 , NSE with an NSE Symbol of AJANTPHARM and ISIN of INE031B01049. It's Registered office is at Ajanta House,Charkop ,Kandivali (W)Mumbai-400067, Maharashtra. Their Registrars are ACC Ltd. It's auditors are BSR & Co LLP, Kapoor & Parekh Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)